GPC3 and metastatic neoplasm: While classical markers, such as HepPar1, Arg-1, and GPC3, remain foundational for distinguishing HCC from benign lesions and metastatic tumors, their limitations in specificity and sensitivity underscore the need for combinatorial approaches.